Raymond James Financial Inc Heron Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 136,222 shares of HRTX stock, worth $256,097. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136,222
Previous 135,722
0.37%
Holding current value
$256,097
Previous $207,000
44.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
182Shares Held
125MCall Options Held
847KPut Options Held
47.7K-
Rubric Capital Management LP New York, NY26.7MShares$50.2 Million1.68% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$15.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$15.5 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$14.8 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13.1 Million26.51% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $223M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...